We focused on the expression of symbolic genes CA125 and HE4 and immune checkpoint genes PD-1, PD-L1, PD-L2, and CTLA4 in different groups of ovarian cancer so as to further explore the correlation between histone acetylation and the progress, treatment, and prognosis of ovarian cancer. This evidence concerns the gene MUC16 and ovarian carcinoma.